FDA Adverse Event Malfunction Summary report: N

COAGUCHEK ® XS SYSTEM

MDR report key: 7174553 · Received January 9, 2018

Report

Report Number
1823260-2018-00088
Event Type
Malfunction
Date Received
January 9, 2018
Date of Event
December 25, 2017
Report Date
February 26, 2018
Manufacturer
ROCHE DIAGNOSTICS
Product Code
GJS
PMA / PMN Number
K062925
Removal / Correction Number
NA
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
US
Reporter Occupation
PATIENT

Narratives

Additional Manufacturer Narrative · 1

(B)(4).

Additional Manufacturer Narrative · 1

AS NO CUSTOMER MATERIAL WAS RECEIVED, THE INVESTIGATION WAS UNABLE TO FIND A DEFINITIVE ROOT CAUSE.

Description of Event or Problem · 1

THE CUSTOMER RECEIVED QUESTIONABLE RESULTS FROM COAGUCHEK XS METER SERIAL NUMBER (B)(4). ON (B)(6) 2017 AT 2:15 AM, THE RESULT WAS 2.5 INR. ON (B)(6) 2017 AT 2:48 AM, THE RESULT WAS 4.8 INR. AT 2:56 AM, THE RESULT WAS 2.4 INR. AT 3:00 AM, THE RESULT WAS 2.2 INR. AT 3:17 AM, THE RESULT WAS 2.9 INR. AT 4:59 AM, THE RESULT WAS 3.4 INR. THE CUSTOMER WAS THEN TESTED IN A LABORATORY WITH AN UNKNOWN REAGENT AND THE RESULT WAS 2.38 INR. THERE WAS NO ALLEGATION OF AN ADVERSE EVENT. THE CUSTOMER TOOK NO ALTERNATE THINNERS, HAD NO ANTIPHOSPHOLIPID ANTIBODIES, NO TEMPORARY MEDICATION, AND NO DIET OR HEALTH FLUCTUATIONS. THE THERAPEUTIC RANGE WAS 2.5-3.5 INR. THE METER AND STRIPS WERE REQUESTED TO BE RETURNED FOR FURTHER INVESTIGATION. RELEVANT RETENTION TEST STRIPS (LOT 250321-12) WERE TESTED IN COMPARISON WITH THE CURRENT MASTER LOT COAGUCHEK XS PT TEST STRIP (LOT 124158-80). FOR THIS PURPOSE, TWO HUMAN BLOOD SAMPLES FROM MARCUMAR DONORS AND TWO INTERNAL REFERENCE METERS WERE USED. NO ERROR MESSAGES OCCURRED. RETENTION SAMPLES WERE ACCEPTABLE AND RETENTION MATERIAL PERFORMED AS SPECIFIED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
18798 COAGUCHEK ® XS SYSTEM PROTHROMBIN TIME TEST STRIPS GJS ROCHE DIAGNOSTICS NA 25032112

Patients

Seq Age Sex Outcome Treatment
1 57 YR